Synthesis and topoisomerase I inhibitory properties of luotonin A analogues

被引:67
作者
Cagir, A
Eisenhauer, BM
Gao, R
Thomas, SJ
Hecht, SM
机构
[1] Univ Virginia, Dept Chem, Charlottesville, VA 22901 USA
[2] Univ Virginia, Dept Biol, Charlottesville, VA 22901 USA
关键词
camptothecin; luotonin A; topoisomerase I-DNA inhibition; structure-activity relationships;
D O I
10.1016/j.bmc.2004.08.052
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Luotonin A, a naturally occurring pyrroloquinazolinoquinoline alkaloid, has been previously demonstrated to be a topoisomerase I poison. A number of luotonin A derivatives have now been prepared through the condensation of anthranilic acid derivatives and 1, 2-dihydropyrrolo [3,4-b]quinoline-3-one in the presence of phosphorus oxychloride. When dichloromethane was used as solvent the reaction proceeded to a single product. In contrast when the reaction was carried out in tetrahydrofuran or in phosphorus oxychloride, an additional isomeric product was obtained. The luotonin A analogues were evaluated for their ability to effect stabilization of the covalent binary complex formed between human topoisomerase I and DNA, and for cytotoxicity toward a yeast strain expressing the human topoisomerase I. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6287 / 6299
页数:13
相关论文
共 44 条
[11]  
HSIANG YH, 1985, J BIOL CHEM, V260, P4873
[12]  
JAXEL C, 1989, CANCER RES, V49, P1465
[13]   Total synthesis of luotonin A [J].
Kelly, TR ;
Chamberland, S ;
Silva, RA .
TETRAHEDRON LETTERS, 1999, 40 (14) :2723-2724
[14]   RIGID ANALOGS OF CAMPTOTHECIN AS DNA TOPOISOMERASE-I INHIBITORS [J].
LACKEY, K ;
BESTERMAN, JM ;
FLETCHER, W ;
LEITNER, P ;
MORTON, B ;
STERNBACH, DD .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (06) :906-911
[15]   Water soluble inhibitors of topoisomerase I: Quaternary salt derivatives of camptothecin [J].
Lackey, K ;
Sternbach, DD ;
Croom, DK ;
Emerson, DL ;
Evans, MG ;
Leitner, PL ;
Luzzio, MJ ;
McIntyre, G ;
Vuong, A ;
Yates, J ;
Besterman, JM .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (03) :713-719
[16]   Human topoisomerase I inhibition: Docking camptothecin and derivatives into a structure-based active site model [J].
Laco, GS ;
Collins, JR ;
Luke, BT ;
Kroth, H ;
Sayer, JM ;
Jerina, DM ;
Pommier, Y .
BIOCHEMISTRY, 2002, 41 (05) :1428-1435
[17]   BN 80245: An E-ring modified camptothecin with potent antiproliferative and topoisomerase I inhibitory activities [J].
Lavergne, O ;
LesueurGinot, L ;
Rodas, FP ;
Bigg, DCH .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (17) :2235-2238
[18]   Homocamptothecins:: Synthesis and antitumor activity of novel E-ring-modified camptothecin analogues [J].
Lavergne, O ;
Lesueur-Ginot, L ;
Rodas, FP ;
Kasprzyk, PG ;
Pommier, J ;
Demarquay, D ;
Prévost, G ;
Ulibarri, G ;
Rolland, A ;
Schiano-Liberatore, AM ;
Harnett, J ;
Pons, D ;
Camara, J ;
Bigg, DCH .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (27) :5410-5419
[19]   A facile synthesis of simple alkaloids -: synthesis of 2,3-polymethylene-4(3H)-quinazolinones and related alkaloids [J].
Lee, ES ;
Park, JG ;
Jahng, Y .
TETRAHEDRON LETTERS, 2003, 44 (09) :1883-1886
[20]   SYNTHESIS AND ANTITUMOR-ACTIVITY OF NOVEL WATER-SOLUBLE DERIVATIVES OF CAMPTOTHECIN AS SPECIFIC INHIBITORS OF TOPOISOMERASE-I [J].
LUZZIO, MJ ;
BESTERMAN, JM ;
EMERSON, DL ;
EVANS, MG ;
LACKEY, K ;
LEITNER, PL ;
MCINTYRE, G ;
MORTON, B ;
MYERS, PL ;
PEEL, M ;
SISCO, JM ;
STERNBACH, DD ;
TONG, WQ ;
TRUESDALE, A ;
UEHLING, DE ;
VUONG, A ;
YATES, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (03) :395-401